TR200003588T2 - Biyolojik olarak aktif bileşim - Google Patents

Biyolojik olarak aktif bileşim

Info

Publication number
TR200003588T2
TR200003588T2 TR2000/03588T TR200003588T TR200003588T2 TR 200003588 T2 TR200003588 T2 TR 200003588T2 TR 2000/03588 T TR2000/03588 T TR 2000/03588T TR 200003588 T TR200003588 T TR 200003588T TR 200003588 T2 TR200003588 T2 TR 200003588T2
Authority
TR
Turkey
Prior art keywords
biologically active
composition
question
carrier
matrix
Prior art date
Application number
TR2000/03588T
Other languages
English (en)
Turkish (tr)
Inventor
Lindahl Ake
Hagslatt Hakan
Benediktsson Catharina
Bryland Rickard
Original Assignee
Bioglan Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioglan Ab filed Critical Bioglan Ab
Publication of TR200003588T2 publication Critical patent/TR200003588T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
TR2000/03588T 1998-05-14 1999-05-12 Biyolojik olarak aktif bileşim TR200003588T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801705A SE9801705D0 (sv) 1998-05-14 1998-05-14 Biologically active composition

Publications (1)

Publication Number Publication Date
TR200003588T2 true TR200003588T2 (tr) 2001-06-21

Family

ID=20411319

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03588T TR200003588T2 (tr) 1998-05-14 1999-05-12 Biyolojik olarak aktif bileşim

Country Status (20)

Country Link
EP (1) EP1077677B1 (https=)
JP (1) JP2002514588A (https=)
KR (1) KR100766998B1 (https=)
CN (1) CN1309554A (https=)
AT (1) ATE252371T1 (https=)
AU (1) AU742921B2 (https=)
CA (1) CA2332110A1 (https=)
DE (2) DE69912271T2 (https=)
DK (1) DK1077677T3 (https=)
ES (1) ES2155049T3 (https=)
GR (1) GR20010300014T1 (https=)
HU (1) HUP0102002A3 (https=)
IL (2) IL139577A0 (https=)
NO (1) NO20005725L (https=)
NZ (1) NZ508074A (https=)
PL (1) PL344221A1 (https=)
SE (1) SE9801705D0 (https=)
TR (1) TR200003588T2 (https=)
WO (1) WO1999058109A1 (https=)
ZA (1) ZA200006476B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003524652A (ja) * 2000-02-29 2003-08-19 ツァン,ツィエ 改良された経皮薬剤パッチ
WO2005013939A1 (en) 2003-08-06 2005-02-17 Nirmal Mulye Pharmaceutical composition containing water soluble drug
KR20090031726A (ko) 2006-06-14 2009-03-27 닥터 레디스 레보러터리즈 리미티드 국소용 조성물
WO2012028496A1 (de) * 2010-08-31 2012-03-08 Basf Se Verzweigte polyester auf basis von zitronensäure sowie deren herstellung und verwendung
KR20140089478A (ko) * 2011-01-13 2014-07-15 큐엘티 인코포레이티드 감광제의 국소 전달용 약학 조성물 및 그의 이용

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
SE9502244D0 (sv) * 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
GB2306885B (en) * 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions

Also Published As

Publication number Publication date
HUP0102002A3 (en) 2002-12-28
HUP0102002A2 (hu) 2002-03-28
ATE252371T1 (de) 2003-11-15
CA2332110A1 (en) 1999-11-18
DK1077677T3 (da) 2004-02-16
JP2002514588A (ja) 2002-05-21
IL139577A0 (en) 2002-02-10
SE9801705D0 (sv) 1998-05-14
EP1077677B1 (en) 2003-10-22
GR20010300014T1 (en) 2001-04-30
AU742921B2 (en) 2002-01-17
ZA200006476B (en) 2001-06-11
WO1999058109A1 (en) 1999-11-18
ES2155049T1 (es) 2001-05-01
KR100766998B1 (ko) 2007-10-15
AU4405199A (en) 1999-11-29
NZ508074A (en) 2003-01-31
DE69912271D1 (de) 2003-11-27
CN1309554A (zh) 2001-08-22
DE69912271T2 (de) 2004-08-26
NO20005725L (no) 2001-01-11
KR20010052349A (ko) 2001-06-25
ES2155049T3 (es) 2004-05-16
EP1077677A1 (en) 2001-02-28
DE1077677T1 (de) 2001-09-20
PL344221A1 (en) 2001-10-08
NO20005725D0 (no) 2000-11-13
IL139577A (en) 2007-07-04

Similar Documents

Publication Publication Date Title
ES2147320T3 (es) Derivados de n-(3-benzofuranil)urea.
YU18799A (sh) Monociklični l-nukleozidi, njihovi analozi i njihova upotreba
TR200100623T2 (tr) 5-Tia-w-ikameli fenil-prostaglandin türevleri, bunları üretme yöntemleri ve müessir madde olarak bunları ihtiva eden ilaçlar
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
DE60029799D1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
BR9909110A (pt) Usos de esmilagenina e anzurogenina d, compoisção farmacêutica tendo propriedades intensificadoras da função cognitiva, processo para intensificar a função cognitiva, e, composição para uso do mesmo
ATE154029T1 (de) 7-deazapurin modifizierte oligonukleotide
FR2854335B1 (fr) Traitement hors site de catalyseurs d'hydrogenation
BR0007589A (pt) Inibidores da proliferação de células
ATE298741T1 (de) Polyaromatische verbindungen zur behandlung von herpes-infektionen
DE60234577D1 (de) Pharmazeutische mischung zur behandlung von krebs, die dioxolan nukleosidanalogen enthält
ID18038A (id) Metode pembuatan alat pelapas terkontrol
EP1005349A4 (en) USE OF COMPOUNDS CONTAINING CYTOSINE OR CYTIDINE FOR THE TREATMENT OF THE USE OF STIMULANTS
NO20060631L (no) Fast dispersjon av takrolimus
TR200003588T2 (tr) Biyolojik olarak aktif bileşim
DE60135482D1 (de) Eukaryontische zellteilungsgene und deren verwendung in der diagnostik sowie in der behandlung von proliferativen erkrankungen
RU2008125106A (ru) Композиция для обработки волос, содержащая акриловый адгезив, чувствительный к давлению
TR200003589T2 (tr) Biyolojik olarak aktif bileşim.
KR880013569A (ko) 에이즈(aids) 치료제
DK0975588T3 (da) Antipicornavirale forbindelser, sammensætninger indeholdende dem og fremgangsmåder til deres anvendelse
PT1059921E (pt) Utilizacao de compostos macrolitos para o tratamento de sdra
DE69007374D1 (de) Injektionssystem für die Behandlung von Zellen.
ATE532509T1 (de) Mittel zur hemmung des eintritts des hiv-virus
ES2032797T3 (es) Agente terapeutico para el tratamiento de la enfermedad ulcera peptica.
ATE260111T1 (de) Mittel zur behandlung von autoimmunkrankheiten